KREBS BIOCHEMICALS & INDUSTRIES Financial Statement Analysis
|
||
|
The Revenues of KREBS BIOCHEMICALS & INDUSTRIES have increased by 11.18% YoY .
The Earnings Per Share (EPS) of KREBS BIOCHEMICALS & INDUSTRIES has decreased by Negative YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Annual Financial Results
[BOM: 524518|NSE : KREBSBIO]
| Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹60 Cr | ₹54 Cr | ₹33 Cr | ₹48 Cr | ₹34 Cr |
| Expenses | ₹94 Cr | ₹71 Cr | ₹52 Cr | ₹58 Cr | ₹41 Cr |
| Operating Profit (Excl OI) | ₹-34 Cr | ₹-18 Cr | ₹-19 Cr | ₹-9.76 Cr | ₹-7.50 Cr |
| Other Income | ₹1.16 Cr | ₹0.62 Cr | ₹0.37 Cr | ₹0.33 Cr | ₹0.21 Cr |
| Interest | ₹5.39 Cr | ₹6.28 Cr | ₹6.00 Cr | ₹6.29 Cr | ₹5.17 Cr |
| Depreciation | ₹6.30 Cr | ₹5.12 Cr | ₹4.68 Cr | ₹4.40 Cr | ₹4.15 Cr |
| Profit Before Tax | ₹-45 Cr | ₹-28 Cr | ₹-29 Cr | ₹-20 Cr | ₹-18 Cr |
| Profit After Tax | ₹-45 Cr | ₹-28 Cr | ₹-29 Cr | ₹-20 Cr | ₹-18 Cr |
| Consolidated Net Profit | ₹-45 Cr | ₹-28 Cr | ₹-29 Cr | ₹-20 Cr | ₹-18 Cr |
| Earnings Per Share (Rs) | ₹-11.45 | ₹-20.65 | ₹-14.45 | ₹-16.04 | ₹-12.03 |
| PAT Margin (%) | -47.36 | -74.58 | -52.81 | -86.41 | -41.90 |
| ROE(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| ROCE(%) | -28.59 | -57.38 | -40.28 | -56.96 | -35.41 |
| Total Debt/Equity(x) | -1.84 | -1.91 | -2.37 | -2.03 | -3.74 |
Key Financials |
||
| Market Cap | : | ₹ 153.7 Cr |
| Revenue (TTM) | : | ₹ 49.9 Cr |
| Net Profit(TTM) | : | ₹ -20.8 Cr |
| EPS (TTM) | : | ₹ -9.6 |
| P/E (TTM) | : | - |
| Industry Peers & Returns | 1W | 1M | 1Y |
| KREBS BIOCHEMICALS & INDUSTRIES | 0.7% | 9.4% | -3.2% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | -2.8% | 50.3% |
| CIPLA | 4.5% | -3.1% | 52.8% |
| DR REDDYS LABORATORIES | 4.6% | 1.4% | 22.2% |
| ZYDUS LIFESCIENCES | 3.1% | -4.1% | 80.4% |
| DIVIS LABORATORIES | 4.7% | 10.8% | 18.1% |
| MANKIND PHARMA | 2.7% | 12.4% | NA |
| TORRENT PHARMACEUTICALS | 6.1% | 5.3% | 66.2% |
| LUPIN | 3.1% | -1.1% | 127.4% |
KREBS BIOCHEMICALS & INDUSTRIES Revenues
[BOM: 524518|NSE : KREBSBIO]
| Y-o-Y | 11.18 % |
| 5 Yr CAGR | 15.30 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹60 Cr | 11.18 | |
| Mar2022 | ₹54 Cr | 60.72 | |
| Mar2021 | ₹33 Cr | -30.04 | |
| Mar2020 | ₹48 Cr | 41.38 | |
| Mar2019 | ₹34 Cr | - | |
KREBS BIOCHEMICALS & INDUSTRIES Operating Profit
[BOM: 524518|NSE : KREBSBIO]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹-34 Cr | Negative | |
| Mar2022 | ₹-18 Cr | Negative | |
| Mar2021 | ₹-19 Cr | Negative | |
| Mar2020 | ₹-9.76 Cr | Negative | |
| Mar2019 | ₹-7.50 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | -56.94% | Negative | |
| Mar2022 | -32.73% | Negative | |
| Mar2021 | -55.53% | Negative | |
| Mar2020 | -20.44% | Negative | |
| Mar2019 | -22.21% | - | |
KREBS BIOCHEMICALS & INDUSTRIES Profit After Tax
[BOM: 524518|NSE : KREBSBIO]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹-45 Cr | Negative | |
| Mar2022 | ₹-28 Cr | Negative | |
| Mar2021 | ₹-29 Cr | Negative | |
| Mar2020 | ₹-20 Cr | Negative | |
| Mar2019 | ₹-18 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | -47.36 % | Negative | |
| Mar2022 | -74.58 % | Negative | |
| Mar2021 | -52.81 % | Negative | |
| Mar2020 | -86.41 % | Negative | |
| Mar2019 | -41.9 % | - | |
KREBS BIOCHEMICALS & INDUSTRIES Earnings Per Share (EPS)
[BOM: 524518|NSE : KREBSBIO]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹-11 | Negative | |
| Mar2022 | ₹-21 | Negative | |
| Mar2021 | ₹-14 | Negative | |
| Mar2020 | ₹-16 | Negative | |
| Mar2019 | ₹-12 | - | |
KREBS BIOCHEMICALS & INDUSTRIES Return on Capital Employed (ROCE)
[BOM: 524518|NSE : KREBSBIO]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | -28.59% | Negative | |
| Mar2022 | -57.38% | Negative | |
| Mar2021 | -40.28% | Negative | |
| Mar2020 | -56.96% | Negative | |
| Mar2019 | -35.41% | - | |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
| Current Share Price | : | ₹71.2 |
| Current MarketCap | : | ₹ 153.7 Cr |
| Updated EOD on | : | Apr 25,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KREBS BIOCHEMICALS & INDUSTRIES | 0.7% |
9.4% |
-3.2% |
| SENSEX | 1.3% |
2.6% |
24% |
KREBS BIOCHEMICALS & INDUSTRIES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about KREBS BIOCHEMICALS & INDUSTRIES Financials
How the annual revenues of KREBS BIOCHEMICALS & INDUSTRIES have changed ?
The Revenues of KREBS BIOCHEMICALS & INDUSTRIES have increased by 11.18% YoY .
How the Earnings per Share (EPS) of KREBS BIOCHEMICALS & INDUSTRIES have changed?
The Earnings Per Share (EPS) of KREBS BIOCHEMICALS & INDUSTRIES has decreased by Negative YoY .
Check out Intrinsic Value of Peers of KREBS BIOCHEMICALS & INDUSTRIES
Compare Stock Analytics of Peers of KREBS BIOCHEMICALS & INDUSTRIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
